Ophthalmology · River Falls, WI
NPI
1922077106
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
183 E Pomeroy St
River Falls, WI, 54022
Phone (715) 425-0115
Groups this clinician bills Medicare through
Medicare paid, 2024
$608K
7,518 services
Medicare patients, 2024
650
Average age 75
Drug cost, 2024
$169K
2,220 prescriptions
Company payments, 2025
$31.99
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anthony F Novak was code J2777 (injection, faricimab-svoa, 0.1 mg), 3,481 times for 12 patients. In total Anthony F Novak billed 7,518 services in 68 codes, and Medicare paid $608K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-01-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2777 Injection, faricimab-svoa, 0.1 mg | Office | 3,481 | 12 | $27.40 | $95K |
| 67028 Intravitreal Injection | Office | 375 | 70 | $87.39 | $33K |
| J0178 Injection, aflibercept, 1 mg | Office | 357 | 33 | $632.30 | $226K |
| 92014 Ophthalmological E&M | Office | 347 | 339 | $62.22 | $22K |
| 99213 Office E&M - Established | Office | 300 | 164 | $56.71 | $17K |
| 92134 Computerized Ophthalmic Imaging | Office | 230 | 164 | $24.79 | $5,703 |
| J9035 Injection, bevacizumab, 10 mg | Office | 192 | 37 | $54.40 | $10K |
| 92136 Ultrasound - Nonspecific | Office | 166 | 100 | $25.47 | $4,229 |
| 92133 Computerized Ophthalmic Imaging | Office | 156 | 152 | $19.50 | $3,042 |
| 66984 Cataract Surgery | Facility | 153 | 90 | $357.80 | $55K |
| 92004 Ophthalmological E&M | Office | 132 | 132 | $82.11 | $11K |
| 92083 Vision, Hearing, and Speech Services | Office | 130 | 126 | $37.50 | $4,875 |
| 66821 Cataract Surgery | Office | 121 | 85 | $232.10 | $28K |
| 83861 Clinical Chemistry | Office | 80 | 39 | $22.03 | $1,762 |
| 92250 Angiography | Office | 55 | 55 | $21.04 | $1,157 |
By year: 2022 $679K for 4,046 services; 2023 $682K for 5,815 services; 2024 $608K for 7,518 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83861 Clinical Chemistry | 80 | 39 | $22.03 | $1,762 |
Medicare prescription drug claims, 2024
In 2024, the drug Anthony F Novak prescribed most often to Medicare patients was Latanoprost, with 294 prescriptions and refills. In total Anthony F Novak wrote 2,220 Medicare prescriptions that cost $169K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 294 | 474 | 76 | $2,201 |
| Ketorolac Tromethamine Generic | 232 | 240 | 155 | $4,135 |
| Moxifloxacin Moxifloxacin Hcl | 212 | 212 | 124 | $4,354 |
| Timolol Maleate Generic | 183 | 346 | 64 | $1,770 |
| Prednisolone Acetate Generic | 173 | 236 | 116 | $7,933 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 169 | 337 | 53 | $2,961 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 160 | 163 | 116 | $1,969 |
| Brimonidine Tartrate Generic | 102 | 181 | 35 | $4,077 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 76 | 78 | 50 | $2,896 |
| Doxycycline Hyclate Generic | 52 | 107 | 20 | $1,462 |
| Lumigan Bimatoprost | 36 | 66 | 13 | $16K |
| Alphagan P Brimonidine Tartrate | 31 | 48 | Under 11 | $9,287 |
| Dexamethasone Sodium Phosphate Generic | 31 | 31 | 22 | $2,084 |
| Fluorometholone Generic | 29 | 54 | 11 | $1,834 |
| Restasis Cyclosporine | 28 | 44 | Under 11 | $25K |
Brand drugs: 699 claims; generic drugs: 1,521 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anthony F Novak $31.99 ($31.99 in general payments such as food, travel and fees) from 1 company. The largest payer was Alcon Vision LLC with $31.99.
| Company | Payments | Amount |
|---|---|---|
| Alcon Vision LLC ALC | 1 | $31.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.